跳至主要内容
临床试验/NCT03808285
NCT03808285已完成不适用

Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2013年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
13
试验地点
1
主要终点
Rate of mandibular osteomyelitis

研究概览

简要总结

The aim of this study is to adescription of mandibular osteomylitis in patients having had a treatment by DENOSUMAB. Indeed, one of the adverse effect ot this molecule is to induce mandibular infection.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients having a mandibular osteomylelitis due to DENOSUMAB

排除标准

  • 未提供

结局指标

主要结局

Rate of mandibular osteomyelitis

时间窗: Entire description can be made at the outcome which is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption

description of mandibular osteomyelitis

次要结局

  • Duration of antibiotics(Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)
  • Rate of Treatment Failure(Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)
  • management of mandibular osteomyelitis by medical team(all data are available at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eugénie MABRUT

Clinical Research Assistant

Hospices Civils de Lyon

研究点 (1)

Loading locations...

相似试验